Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 31722-736

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 31722-736). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Eetcontlabel30s (Eetcontlabel30s)

This is a description for a medication named "Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets". Each film coated tablet contains 600 mg of efavirenz USP, 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate, which is equivalent to 245 mg of tenofovir disoproxi. It is a prescribed medication and must only be dispensed in the original container. You can find the Patient Information at ttp//camberpharma com/medication-ouides. For the dosage and administration guidelines, refer to the package insert. The medication should be stored at a temperature range of 20° to 25°C (68° to 77°F) [see USP Controled Room Temperature].*

FDA Label Image

Efavirenzstructure (Efavirenzstructure)

FDA Label Image

Emtricitabinestructure (Emtricitabinestructure)

FDA Label Image

Tenofovirdfstructure (Tenofovirdfstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.